Skip Content
You are currently on the new version of our website. Access the old version .

Journal of Pharmaceutical and BioTech Industry, Volume 2, Issue 3

2025 September - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Review
  • Open Access
986 Views
21 Pages

The growing threat of Antimicrobial Resistance (AMR) demands innovative drug discovery, yet conventional 2D cell cultures fail to accurately mimic in vivo conditions, leading to high failure rates in preclinical studies. This review addresses the cri...

  • Article
  • Open Access
1 Citations
1,284 Views
14 Pages

Modeling Power Consumption: A Novel Correlation for Stirred Media Mills with Variable Bead Filling Ratios

  • Simay Ozsoysal,
  • Hamidreza Heidari,
  • Gulenay Guner,
  • Donald J. Clancy and
  • Ecevit Bilgili

Evaluating power consumption in stirred media mills over a wide range of process parameters is crucial for analyzing breakage kinetics and milling efficiency. Despite considerable research efforts, existing models predominantly rely on power-law appr...

  • Opinion
  • Open Access
1 Citations
1,488 Views
5 Pages

Current estimates suggest that Africa contains about 14% of the world’s population and accounts for 20% of the global burden of disease. Yet, it accounts for a mere 3% of clinical trials globally. The time is ripe—even overdue—for d...

  • Article
  • Open Access
3,741 Views
10 Pages

Background: Off-label nebulization of tranexamic acid (TXA) solution is common practice for the treatment of hemoptysis. However, data regarding nebulization protocols, resulting aerodynamic parameters of the generated aerosol, and corresponding biop...

  • Review
  • Open Access
4 Citations
6,687 Views
29 Pages

Developing a new drug costs approximately one to three billion dollars and takes around ten years; however, this process has only a ten percent success rate. To address this issue, new technologies that combine artificial intelligence (AI) and quantu...

  • Article
  • Open Access
849 Views
13 Pages

PMSSO-Hydrogels as a Promising Carrier for B12 Vitamin

  • Daniil Ialama,
  • Polina Orlova,
  • Anna Skuredina,
  • Ivan Meshkov,
  • Aziz Muzafarov and
  • Irina Le-Deygen

The development of novel dosage forms of vitamin B12 is an urgent task for addressing vitamin deficiency in individuals with gastrointestinal diseases or those following stringent dietary limitations. The study illustrates the fundamental possibility...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Pharm. BioTech Ind. - ISSN 2813-9380